NYMEX denied several traders (see here, here, here, here and here) and a trading firm (see here) direct or indirect access to any Chicago Mercantile Exchange ("CME") trading floor for failure to cooperate in an investigation of suspected trading anomalies.

In an investigation conducted by the CME Group's Market Regulation Department ("MRD"), the trading firm and several traders employed by the firm impaired the MRD's investigation by:

  • denying any association with an outside trader in a particular instance, even though the MRD found at least one apparent transfer of funds from the firm to the trader in the firm's records;

  • refusing to submit complete information, and/or submitting insufficient information in response to MRD document requests; and

  • giving false information during investigative interviews.

The MRD also found that the trading firm and its traders exhibited other "anomalous" patterns of trading activity, including connections with traders suspended by CME Group markets or subject to trade practice investigations.

NYMEX stated that the trading firm and traders are denied access to any form of trading activity on CME Group markets until January 16, 2020.

Primary Sources

  1. NYMEX Notice of Summary Access Denial Action: Jinlin Tian
  2. NYMEX Notice of Summary Access Denial Action: Damien Yeo
  3. NYMEX Notice of Summary Access Denial Action: Thomas Lim
  4. NYMEX Notice of Summary Access Denial Action: Michael Lim
  5. NYMEX Notice of Summary Access Denial Action: Aaron Dao Chang Pang
  6. NYMEX Notice of Summary Access Denial Action: 3 Crowns Capital